Mackenzie Financial’s Pacific Biosciences PACB Stock Holding History

Mackenzie Financial’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,499	Closed	-$30.2K	–	1663
2025 Q4	$30.2K	Hold	17,499	–	–	﹤0.01%	1637
2025 Q3	$22.4K	Hold	17,499	–	–	﹤0.01%	1684
2025 Q2	$21.7K	Buy	17,499 +2,409	+16%	+$2.78K	﹤0.01%	1677
2025 Q1	$17.8K	Hold	15,090	–	–	﹤0.01%	1650
2024 Q4	$27.6K	Hold	15,090	–	–	﹤0.01%	1678
2024 Q3	$25.7K	Hold	15,090	–	–	﹤0.01%	1562
2024 Q2	$20.7K	Hold	15,090	–	–	﹤0.01%	1518
2024 Q1	$56.6K	Hold	15,090	–	–	﹤0.01%	1477
2023 Q4	$148K	Hold	15,090	–	–	﹤0.01%	1371
2023 Q3	$118K	Hold	15,090	–	–	﹤0.01%	1334
2023 Q2	$195K	Hold	15,090	–	–	﹤0.01%	1343
2023 Q1	$175K	Hold	15,090	–	–	﹤0.01%	1360
2022 Q4	$123K	Hold	15,090	–	–	﹤0.01%	1304
2022 Q3	$88K	Sell	15,090 -265	-2%	-$1.52K	﹤0.01%	1316
2022 Q2	$68K	Buy	15,355 +4,441	+41%	+$27K	﹤0.01%	1369
2022 Q1	$99K	Buy	10,914 +283	+3%	+$3.26K	﹤0.01%	1338
2021 Q4	$218K	Sell	10,631 -754	-7%	-$18.2K	﹤0.01%	1301
2021 Q3	$291K	Buy	11,385 +4,710	+71%	+$140K	﹤0.01%	1148
2021 Q2	$233K	Buy	+6,675	New	+$194K	﹤0.01%	1129

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Mackenzie Financial's PACB Position: Q1 2026 in Review

Mackenzie Financial sold out of Pacific Biosciences (PACB) in Q1 2026, closing a stake of 17,499 shares — an estimated $30.2K sold.

Mackenzie Financial first reported a position in PACB in Q2 2021 and held it in 19 quarters. The position peaked at $291K in Q3 2021. 231 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

Mackenzie Financial reported no remaining Pacific Biosciences position as of Q1 2026 after selling out during the quarter.
Mackenzie Financial sold 17,499 Pacific Biosciences shares in Q1 2026, an estimated $30.2K.
Mackenzie Financial first reported a position in Pacific Biosciences in Q2 2021 and held it in 19 quarters.
Mackenzie Financial's Pacific Biosciences position peaked at $291K in Q3 2021.
231 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.